Abstract
Varying degrees of metabolic abnormalities mediated by chronic inflammation are implicated in the chronic glomerular injuries associated with obesity. Interleukin (IL)-10, a pleiotropic cytokine, exerts anti-inflammatory effects in numerous biological settings. In the present study, we explored the biological benefits of adeno-associated virus (AAV) vector-mediated sustained IL-10 expression against the pathological renal characteristics observed in Zucker fatty rats (ZFRs). We injected an AAV vector, encoding rat IL-10 or enhanced green fluorescent protein (GFP) into male ZFRs at 5 weeks of age. Subsequently, the renal pathophysiological changes were analyzed. Persistent IL-10 expression significantly reduced the urinary protein excretion of ZFRs compared with GFP expression (47.1±11.6 mg per mg·creatinine versus 88.8±30.0 mg per mg·creatinine, P<0.01). The serum levels of IL-10 negatively correlated with the urinary protein in AAV-treated rats (r=−0.78, P<0.01). Renal hypertrophy, increased widths in the glomerular basement membrane, and the lack of uniformity and regularity of the foot process of the visceral glomerular epithelial cells of ZFRs were significantly blunted by IL-10 expression. IL-10 also abrogated the downregulation of glomerular nephrin observed in ZFRs treated with the GFP vector. Our findings provide insights into the potential benefit of the anti-inflammatory effects of IL-10 on the overall management of glomerulopathy induced by the metabolic disorders associated with obesity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kambham N, Markowitz GS, Valeri M, Lin J, D’Agati VD . Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 39: 1498–1509.
Ramirez SP, McClellan W, Port FK, Hsu SIH . Risk factors for proteinuria in a large, multiracial, Southeast Asian population. J Am Soc Nephrol 2002; 1: 1907–1917.
Iseki K, Ikemiya K, Kinjo K, Inoue T, Iseki C, Takishita S . Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870–1876.
Hallan S, de Mutsert R, Carlsen S, Dekker FW, Aasarod K, Holmen J . Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis 2006; 47: 396–405.
Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y . The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003; 14: 1480–1486.
Chen HM, Li SJ, Chen HP, Wang QW, Li LS, Liu ZH . Obesity-related glomerulopathy in China: a case series of 90 patients. Am J Kidney Dis 2008; 52: 58–65.
Kasiske BL, Cleary MP, O’Donnell MP, Keane WF . Effects of genetic obesity on renal structure and function in the Zucker rat. J Lab Clin Med 1985; 106: 598–604.
Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H . Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev 1999; 15: 314–322.
Wolf G, Hamann A, Han DC, Helmchen U, Thaiss F, Ziyadeh FN et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells. potential role in glomerulosclerosis. Kidney Int 1999; 56: 860–872.
Keane WF . Lipids and the kidney. Kidney Int 1994; 46: 910–920.
Mu W, Ouyang X, Agarwal A, Zhang L, Long DA, Cruz PE et al. IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease. J Am Soc Nephrol 2005; 16: 3651–3660.
Yoshioka T, Okada T, Maeda Y, Ikeda U, Shimpo M, Nomoto T et al. Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient mice. Gene Therapy 2004; 11: 1772–1779.
Hong EG, Ko HJ, Cho YR, Kim HJ, Ma Z, Yu TY et al. Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes 2009; 58: 2525–2535.
Esposito K, Pontillo A, Giugliano F, Giugliano G, Marfella R, Nicoletti G et al. Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab 2003; 88: 1055–1058.
Coimbra TM, Janssen U, Grone HJ, Ostendorf T, Kunter U, Schmidt H et al. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 2000; 57: 167–182.
Kasiske BL, O’Donnel MP, Cleary MP, Keane WF . Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 1988; 33: 667–672.
Li MC, He SH . IL-10 and its related cytokines for treatment of inflammatory bowel disease. World J Gastroenterol 2004; 10: 620–625.
Ito T, Okada T, Miyashita H, Nomoto T, Nonaka-Sarukawa M, Uchibori R et al. Interleukin-10 expression mediated by an adeno-associated virus vector prevents monocrotaline-induced pulmonary arterial hypertension in rats. Circ Res 2007; 101: 734–741.
Alderson NL, Chachich ME, Youssef NN, Beattie RJ, Nachtigal M, Thorpe SR et al. The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats. Kidney Int 2003; 63: 2123–2133.
Tsilibary EC . Microvascular basement membranes in diabetes mellitus. J Pathol 2003; 200: 537–546.
Caramori ML, Kim Y, Huang C, Fish AJ, Rich SS, Miller ME et al. Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 2002; 51: 506–513.
Akimoto T, Ito C, Saito O, Takahashi H, Takeda S, Ando Y et al. Microscopic hematuria and diabetic glomerulosclerosis—clinicopathological analysis of type 2 diabetic patients associated with overt proteinuria. Nephron Clin Pract 2008; 109: c119–c126.
Fürnsinn C, Komjati M, Madsen OD, Schneider B, Waldhäusl W . Lifelong sequential changes in glucose tolerance and insulin secretion in genetically obese Zucker rats (fa/fa) fed a diabetogenic diet. Endocrinology 1991; 128: 1093–1099.
Sandler S, Welsh N . Interleukin-10 stimulates rat pancreatic islets in vitro, but fails to protect against interleukin-1. Biochem Biophys Res Commun 1993; 195: 859–865.
Sarafidis PA, Ruilope LM . Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol 2006; 26: 232–244.
Bjorn SF, Bangstad HJ, Hanssen KF, Nyberg G, Walker JD, Viberti GC et al. Glomerular epithelial foot processes and filtration slits in IDDM patients. Diabetologia 1995; 38: 1197–1204.
Herbach N, Schairer I, Blutke A, Kautz S, Siebert A, Goke B et al. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and the thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis. Am J Physiol Renal Physiol 2009; 296: F819–F829.
Bonnet F, Cooper ME, Kawachi H, Allen TJ, Boner G, Cao Z . Irbesartan normalizes the deficiency in glomerular nephrin expression in a model of diabetes and hypertension. Diabetologia 2001; 44: 874–877.
Luimula P, Ahola H, Wang SX, Solin ML, Aaltonen P, Tikkanen I et al. Nephrin in experimental glomerular disease. Kidney Int 2000; 58: 1461–1468.
Hollis JH, Lemus M, Evetts MJ, Oldfield BJ . Central interleukin-10 attenuates lipopolysaccharide-induced changes in food intake, energy expenditure and hypothalamic Fos expression. Neuropharmacology 2010; 58: 730–738.
Okada T, Nomoto T, Yoshioka T, Nonaka-Sarukawa M, Ito T, Ogura T et al. Large-scale production of recombinant viruses by use of a large culture vessel with active gassing. Hum Gene Ther 2005; 16: 1212–1218.
Acknowledgements
Part of the work presented in the original manuscript was presented in abstract in the Renal Week 2009 (Annual Meeting of the American Society of Nephrology). We sincerely thank Takashi Yashiro for conducting the electron microscopy studies, and Tom Kouki for his technical assistance in tissue processing for histological and ultrastructural studies.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Ogura, M., Urabe, M., Akimoto, T. et al. Interleukin-10 expression induced by adeno-associated virus vector suppresses proteinuria in Zucker obese rats. Gene Ther 19, 476–482 (2012). https://doi.org/10.1038/gt.2011.183
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2011.183
Keywords
This article is cited by
-
Optimization of adeno-associated virus vector-mediated gene transfer to the respiratory tract
Gene Therapy (2017)
-
Attenuation of methylglyoxal-induced peritoneal fibrosis: immunomodulation by interleukin-10
Laboratory Investigation (2015)
-
Hydrodynamic Delivery of mIL10 Gene Protects Mice From High-fat Diet-induced Obesity and Glucose Intolerance
Molecular Therapy (2013)